Christer Dahlin

Prof. Christer Dahlin

Department of Biomaterials, Institute of Clinical Sciences, University of Gothenburg

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2019 in Journal of Clinical Periodontology
Verified
Journal Article
Open access
PDF file
OOOmar Omar
Omar Omar
IEIbrahim Elgali
Ibrahim Elgali
CDChrister Dahlin
Christer Dahlin
Peter ThomsenPeter Thomsen
Peter Thomsen
Aim: To review the knowledge on the mechanisms controlling membrane–host interactions in guided bone regeneration (GBR) and investigate the possible role ofGBRmembranes as bioactive compartments in addition to their established role as barriers.Materials and Methods: A narrative review was utilized based onin vitro,in vivoand available clinical studies on the cellular and molecular mechanisms underlyingGBRand the possible bioactive role of membranes.Results: Emerging data demonstrate that the membrane contributes bioactively to the regeneration of underlying defects. The cellular and molecular activities in the membrane are intimately linked to the promoted bone regeneration in the underlying defect. Along with the native bioactivity ofGBRmembranes, incorporating growth factors and cells in membranes or with graft materials may augment the regenerative processes in underlying defects.Conclusion: In parallel with its barrier function, the membrane plays an active role in hosting and modulating the molecular activities of the membrane‐associated cells duringGBR. The biological events in the membrane are linked to the bone regenerative and remodelling processes in the underlying defect. Furthermore, the bone‐promoting environments in the two compartments can likely be boosted by strategies targeting both material aspects of the membrane and host tissue responses.

Verified
Journal Article
Open access
PDF file
FAFarah Asa'ad
Farah Asa'ad
CGCarlos Garaicoa
Carlos Garaicoa
CDChrister Dahlin
Christer Dahlin
LLLena Larsson
Lena Larsson
Aim: The purpose of this review was to evaluate the expression patterns of miRNAs in periodontal and peri-implant diseases, while identifying potential miRNAs with the greatest diagnostic ability as an oral fluid biomarker. Materials and methods: Human and animal studies were included when evaluating expression of miRNAs between health and different forms/stages of diseases, in which microarray and/or real-time polymerase chain reaction (RT-PCR) was carried out to detect fold changes in gene expression. After full-text analysis, 43 articles were considered for a qualitative assessment, and 16 miRNAs were selected to perform meta-analysis. Results: Based on human studies, results showed an overall upregulation of most of the evaluated miRNAs in periodontitis, with miRNA-142-3p and miRNA-146a being the most conclusive on both microarray and RT-PCR values and potentially serving as diagnostic biomarkers for disease activity. Conversely, miR-155 was the only miRNA revealing a statistically significant difference (SSD) (p < 0.05*) in experimental periodontitis models from RT-PCR values. Scarce scientific evidence is available from peri-implant diseases, however, most explored miRNAs in peri-implantitis were downregulated except for miR-145. Conclusions: Although our results revealed that a distinct differential expression of specific miRNAs can be noted between the state of health and disease, future research remains necessary to explore the functional role of specific miRNAs and their potential as therapeutic targets in periodontal and peri-implant diseases. MeSH Terms: periodontitis, peri-implantitis, epigenomics, microarray analysis, real-time polymerase chain reaction, microRNAs. Clinical relevance: Scientific background: Although most research identified different expression levels of miRNAs in periodontal and peri-implant diseases compared to their counterparts, their actual role in the pathogenesis of these conditions remains unclear. Therefore, we aimed to present a systematic review and meta-analysis on the expression patterns of miRNAs in periodontitis and peri-implantitis, while identifying potential miRNAs with the greatest diagnostic ability as an oral fluid biomarker. Principal findings: In periodontitis-related studies, miRNA-142-3p and miRNA-146a were the most conclusive on both microarray and RT-PCR values. Scarce scientific evidence is available from peri-implant diseases. Practical implications: Both miRNA-142-3p and miRNA-146a might serve as future diagnostic biomarkers for disease activity in periodontitis. Yet, future research remains necessary to explore the functional role of specific miRNAs and their potential as therapeutic targets in periodontal and peri-implant diseases.

28 June 2022 in Clinical Oral Implants Research
Verified
Journal Article
Open access
RJRonald E. Jung
Ronald E. Jung
Kathrin BeckerKathrin Becker
Kathrin Becker
SBStefan Bienz
Stefan Bienz
CDChrister Dahlin
Christer Dahlin
NDNikolaos Donos
Nikolaos Donos
JNJosé Nart
José Nart
Objectives: The aim of this study was to comprehensively assess the literature in terms of the effect of peri‐implant mucosal thickness on esthetic outcomes and the efficacy of soft tissue augmentation procedures to increase the mucosal thickness with autogenous grafts or soft tissue substitutes.Material and methods: Two systematic reviews (SR) were performed prior to the consensus meeting to assess the following questions. Review 1, focused question: In systemically healthy patients with an implant‐supported fixed prosthesis, what is the influence of thin as compared to thick peri‐implant mucosa on esthetic outcomes? Review 2, focused question 1: In systemically healthy humans with at least one dental implant (immediate or staged implant), what is the efficacy of connective tissue graft (CTG), as compared to absence of a soft tissue grafting procedure, in terms of gain in peri‐implant soft tissue thickness (STT) reported by randomized controlled clinical trials (RCTs) or controlled clinical trials (CCTs)? Review 2, focused question 2: In systemically healthy humans with at least one dental implant (immediate or staged implant), what is the efficacy of CTG, as compared to soft tissue substitutes, in terms of gain in peri‐implant STT reported by RCTs or CCTs? The outcomes of the two SRs, the consensus statements, the clinical implications, and the research recommendations were discussed and subsequently approved at the consensus meeting during the group and plenary sessions.Conclusions: There was a tendency of superior esthetic outcomes in the presence of a thick mucosa. The connective tissue graft remains the standard of care in terms of increasing mucosa thickness.

5 March 2014 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
CDChrister Dahlin
Christer Dahlin
MOMarcel Obrecht
Marcel Obrecht
MDMichel Dard
Michel Dard
NDNikos Donos
Nikos Donos

Verified
Journal Article
Open access
PDF file
Marcel F. KunrathMarcel F. Kunrath
Marcel F. Kunrath
CDChrister Dahlin
Christer Dahlin
The presence of saliva in the oral environment is relevant for several essential health processes. However, the noncontrolled early saliva interaction with biomaterials manufactured for oral rehabilitation may generate alterations in the superficial properties causing negative biological outcomes. Therefore, the present review aimed to provide a compilation of all possible physical–chemical–biological changes caused by the early saliva interaction in dental implants and materials for oral regeneration. Dental implants, bone substitutes and membranes in dentistry possess different properties focused on improving the healing process when in contact with oral tissues. The early saliva interaction was shown to impair some positive features present in biomaterials related to quick cellular adhesion and proliferation, such as surface hydrophilicity, cellular viability and antibacterial properties. Moreover, biomaterials that interacted with contaminated saliva containing specific bacteria demonstrated favorable conditions for increased bacterial metabolism. Additionally, the quantity of investigations associating biomaterials with early saliva interaction is still scarce in the current literature and requires clarification to prevent clinical failures. Therefore, clinically, controlling saliva exposure to sites involving the application of biomaterials must be prioritized in order to reduce impairment in important biomaterial properties developed for rapid healing.

13 July 2017 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
OOOmar Omar
Omar Omar
ADAnna Dahlin
Anna Dahlin
AGAngelines Gasser
Angelines Gasser
CDChrister Dahlin
Christer Dahlin